Correspondence 0001104659-22-119870 from INVIVO THERAPEUTICS HOLDINGS CORP. (CIK 0001292519)
INVIVO THERAPEUTICS HOLDINGS CORP. (CIK 0001292519)
Date: Nov. 17, 2022 · CIK: 0001292519 · Accession: 0001104659-22-119870
AI Filing Summary & Sentiment
File numbers found in text: 333-268256
Show Raw Text
CORRESP
1
filename1.htm
InVivo Therapeutics Holdings Corp.
One Kendall Square, Suite B14402
Cambridge, MA 02139
November 17, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
InVivo Therapeutics Holdings Corp.
Registration Statement on Form S-1
File No. 333-268256
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities
Act of 1933, as amended, InVivo Therapeutics Holdings Corp. hereby requests acceleration of the effective date of its Registration Statement
on Form S-1 (File No. 333-268256), so that it may become effective at 4:00 p.m. on November 21, 2022, or as soon thereafter as practicable.
[Remainder
of Page Intentionally Left Blank]
Very truly yours,
INVIVO THERAPEUTICS HOLDINGS CORP.
By:
/s/
Richard Toselli
Name: Richard Toselli
Title: President and Chief Executive
Officer
Signature Page to Acceleration
Request